Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Sublocade™ for the Treatment of Opioid Use Disorder

Drug (Brand / Generic)

Sublocade™ / buprenorphine extended-release

Developer

Indivior

Therapy Class

Partial agonist

Current Indication

Opioid use disorder (OUD)

Market Sector

CNS

Development Status

Approved in the US
Expand

Go Top